Byasha Jahangir, MD

Dr. Byasha Jahangir operates a multi-specialty medical practice in New York, NY, offering comprehensive primary care alongside targeted peptide-based weight management programs. The practice integrates endocrinology, dermatology, gastroenterology, cardiology, and podiatry services under one roof, allowing patients to address multiple health concerns without navigating separate referral networks. Dr. Jahangir holds an MD degree and applies evidence-based protocols to metabolic health, with particular emphasis on GLP-1 receptor agonist therapies for patients struggling with obesity, prediabetes, and related cardiovascular risk factors.

The clinic's weight management program centers on two FDA-approved peptide medications: semaglutide and tirzepatide. Semaglutide mimics the glucagon-like peptide-1 hormone to regulate appetite and insulin secretion, while tirzepatide activates both GLP-1 and GIP receptors for dual-pathway metabolic control. Dr. Jahangir conducts baseline blood work to assess thyroid function, hemoglobin A1c, lipid panels, and liver enzymes before initiating therapy, then adjusts dosing based on individual tolerance and weight loss velocity. Patients receive structured follow-up schedules to monitor side effects such as nausea or gastrointestinal changes, with dose titration protocols designed to minimize discomfort while maximizing efficacy. The practice does not offer telehealth for peptide therapy; all consultations and injections occur in-person at the New York location to ensure proper administration technique and real-time clinical assessment.

Dr. Jahangir's training in endocrinology informs her approach to hormone-related weight gain, insulin resistance, and metabolic syndrome. She evaluates patients for underlying conditions such as polycystic ovary syndrome, hypothyroidism, and cortisol dysregulation that may impede weight loss efforts. The practice's cardiology services allow for concurrent management of hypertension and dyslipidemia, conditions frequently comorbid with obesity. Dermatology consultations address skin changes associated with rapid weight loss, including elasticity concerns and acanthosis nigricans. Gastroenterology expertise proves valuable when patients experience peptide-related digestive symptoms or require evaluation for conditions like non-alcoholic fatty liver disease. This integrated model reduces the need for external referrals and enables coordinated care plans that address the full spectrum of obesity-related health issues.

Patients begin with a comprehensive intake appointment where Dr. Jahangir reviews medical history, current medications, prior weight loss attempts, and specific health goals. Blood work is ordered during this visit, with results reviewed at a follow-up appointment before prescribing semaglutide or tirzepatide. The practice provides detailed injection training for subcutaneous administration, including proper needle disposal and refrigeration requirements. Follow-up visits occur every four weeks during the initial titration phase, then extend to every eight to twelve weeks once a maintenance dose is established. Dr. Jahangir emphasizes realistic expectations, discussing typical weight loss trajectories of one to two pounds per week and the importance of dietary modifications and physical activity alongside peptide therapy. The practice does not provide pre-packaged meal plans but offers nutritional guidance tailored to individual metabolic profiles and food preferences.

Located in New York, NY, the practice serves patients throughout Manhattan and the surrounding boroughs who prefer in-person medical care over virtual consultations. The multi-specialty structure allows Dr. Jahangir to coordinate with on-site podiatrists for diabetic foot care and with cardiologists for exercise clearance in patients with significant cardiovascular history. This collaborative environment supports long-term metabolic health rather than short-term weight loss alone. Patients appreciate the continuity of having primary care, endocrine management, and peptide therapy overseen by the same physician who understands their complete health picture. The practice accepts most major insurance plans for primary care and specialty visits, though patients should verify coverage for GLP-1 medications, as formulary restrictions and prior authorization requirements vary widely among carriers.